U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06963684) titled 'Glaucoma Laser Assessment of Stability and Sustainability' on April 30.
Brief Summary: The GLASS Study is designed to help researchers learn whether repeating a non-invasive laser treatment called DSLT (Direct Selective Laser Trabeculoplasty) can better control eye pressure in patients with early-stage glaucoma or ocular hypertension. All participants will receive the laser treatment in both eyes. After three months, one eye will be randomly selected to receive a second treatment, while the other eye will serve as a comparison. The goal is to see whether two treatments work better than one at keeping eye pressure low without using da...